Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-threo-3,4-dihydroxyphenylserine

EU orphan designation number: EU/3/07/465   
Active ingredient: L-threo-3,4-dihydroxyphenylserine
Indication: Treatment of orthostatic hypotension in patients with pure autonomic failure
Sponsor: The Weinberg Group Ltd
3 Straiton View, Straiton Business Park, Midlothian EH20 9QZ United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Centralised Orphan - Designation EMEA/OD/026/07 (2007)3819 of 02/08/2007
11/12/2007 Other procedure
01/04/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/026/07/T/01 (2009)2487 of 27/03/2009
09/11/2010 Other procedure EMA/581017/2010
11/03/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/026/07/T/02 (2011)1683 of 09/03/2011